Document is current

Article History

Received: 27 May 2024

Accepted: 10 December 2024

First Online: 15 January 2025

Competing interests

: Dr. Shirasawa reports personal fees from MSD, personal fees from Asahi Kasei Pharma Corporation, personal fees from AstraZeneca.K.K, during the conduct of the study; Dr. Yoshida reports grants from Takeda, grants from Daiichi Sankyo, grants from AbbVie, grants and personal fees from Ono, grants and personal fees from Novartis, grants and personal fees from Merck Sharp & Dohme, grants from Bristol-Myers Squibb Grants, grants and personal fees from Amgen, personal fees from AstraZeneca.K.K, personal fees from Chugai, personal fees from ArcherDX, personal fees from Eli Lilly, personal fees from Roche, personal fees from Taiho, outside the submitted work; Dr. Matsutani was employee of Repertoire Genesis Inc. during this study and is employee of Maruho Co., Ltd. Dr. Takeyasu has nothing to disclose. Dr. Goto has nothing to disclose. Dr. Yagishita reports personal fees from LSI medience, during the conduct of the study; Dr. Kitano reports grants and personal fees from Astra Zeneca, grants and personal fees from Pfizer, grants and personal fees from Boehringer Ingelheim, personal fees from Taiho, personal fees from Novartis, grants and personal fees from MSD, personal fees from Sumitomo Pharma, grants and personal fees from Eisai, grants from Astellas, grants from Gilead Sciences, grants and personal fees from Ono Pharmaceutical Co., Ltd., personal fees from Bristol-Myers Squibb, grants and personal fees from REGENERON, personal fees from Rakuten Medical, grants from PACT Pharma, grants from Takara Bio Inc., grants and personal fees from GSK, grants and personal fees from Daiichi-Sankyo, grants and personal fees from Chugai, grants from Incyte, personal fees from ImmuniT Research Inc., personal fees from Merck KGaA, grants and personal fees from Takeda, personal fees from United Immunity, personal fees from AMED(Japan Agency for Medical Research and Development), personal fees from JSPS(Japan Society for the Promotion of Science), personal fees from PMDA(Pharmaceuticals and Medical Devices Agency), outside the submitted work; Dr. Kuroda has nothing to disclose. Dr. Hida reports personal fees from MSD, personal fees from Chugai Pharmaceutical, personal fees from AstraZeneca.K.K, personal fees from Ono Pharmaceutical, personal fees from Bristol- Meyers Squibb, personal fees from Pfizer, personal fees from Taiho Pharmaceutical, personal fees from Merck, personal fees from Novartis, personal fees from Nippon Boehringer Ingelheim, personal fees from Nippon Kayaku, personal fees from Daiichi Sankyo, personal fees from Takeda, during the conduct of the study; Dr. Kurata reports personal fees from Daiichi Sankyo, grants from Ono, grants from Nippon Kayaku, grants from Pfizer, grants and personal fees from Bristol-Myers Squibb Grants, personal fees from Amgen, grants and personal fees from AstraZeneca.K.K, grants from Chugai, personal fees from Janssen Pharmaceutical, grants from Eli Lilly, grants and personal fees from MSD, personal fees from Takeda, outside the submitted work; Dr. Ohe reports grants and personal fees from AstraZeneca, grants and personal fees from Chugai, grants and personal fees from Ono, grants and personal fees from BMS, grants and personal fees from Kyorin, personal fees from Celltrion, personal fees from Amgen, personal fees from Nippon Kayaku, personal fees from Boehringer Ingelheim, personal fees from AnHeart Therapeutics Inc, personal fees from PharmaMar, grants and personal fees from Eli Lilly, personal fees from Bayer, grants and personal fees from Pfizer, personal fees from MSD, grants and personal fees from Taiho, personal fees from Kyowa Hakko Kirin, personal fees from Eisai, grants and personal fees from Daiichi-Sankyo, grants from Dainippon- Sumitomo, grants from Novartis,, grants from Takeda, grants from Kissei, grants from Janssen, outside the submitted work.